PHILOGEN
Updates & Highlights
NAVLIN DAILY · 4 days ago
Philogen’s Nidlegy Enters EU Joint Clinical Assessment Following EMA Resubmission
marketscreener.com · 13 days ago
Philogen bought back more than 3,600 treasury shares for over €83,000
Medical Dialogues · about 2 months ago
Sun Pharma Partner Philogen Resubmits EMA Application for Melanoma Therapy Nidlegy
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at PHILOGEN?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentPhilogen’s Nidlegy Enters EU Joint Clinical Assessment Following EMA Resubmission
Philogen’s Nidlegy Enters EU Joint Clinical Assessment Following EMA Resubmission
NAVLIN DAILY · 4 days ago
Philogen bought back more than 3,600 treasury shares for over €83,000
Philogen bought back more than 3,600 treasury shares for over €83,000
marketscreener.com · 13 days ago
Sun Pharma Partner Philogen Resubmits EMA Application for Melanoma Therapy Nidlegy
Sun Pharma Partner Philogen Resubmits EMA Application for Melanoma Therapy Nidlegy
Medical Dialogues · about 2 months ago
Philogen SpA Revenue Breakdown – MIL:PHIL
Philogen SpA Revenue Breakdown – MIL:PHIL
TradingView · about 2 months ago
Philogen SpA Revenue Breakdown – SWB:78Q
Philogen SpA Revenue Breakdown – SWB:78Q
TradingView · about 2 months ago
Philogen Updates Share Buyback as Treasury Stake Nears 0.9% of Capital
Philogen Updates Share Buyback as Treasury Stake Nears 0.9% of Capital
The Globe and Mail · about 2 months ago
Philogen resubmits EMA marketing application for Nidlegy with updated Phase III melanoma data
Philogen resubmits EMA marketing application for Nidlegy with updated Phase III melanoma data
Indian Pharma Post · about 2 months ago
Philogen resubmits EMA marketing application for Nidlegy with updated Phase III melanoma data
Philogen resubmits EMA marketing application for Nidlegy with updated Phase III melanoma data
indianpharmapost.com · about 2 months ago
Sun Pharma partner Philogen resubmits Nidlegy application in Europe
Sun Pharma partner Philogen resubmits Nidlegy application in Europe
pharma.economictimes.indiatimes.com · about 2 months ago
Philogen resubmits EMA marketing application for Nidlegy with updated Phase III melanoma data
Philogen resubmits EMA marketing application for Nidlegy with updated Phase III melanoma data
Indian Pharma Post · about 2 months ago
Sun Pharma Says Philogen Resubmits Marketing Authorization Application To EMA For Nidlegy In Melanoma
Sun Pharma Says Philogen Resubmits Marketing Authorization Application To EMA For Nidlegy In Melanoma
TradingView · about 2 months ago
Philogen Resubmits Nidlegy EMA Application with 33-Month Follow-Up Data
Philogen Resubmits Nidlegy EMA Application with 33-Month Follow-Up Data
scanx.trade · about 2 months ago
Philogen SpA Revenue Breakdown – LS:A2QQB6
Philogen SpA Revenue Breakdown – LS:A2QQB6
TradingView · about 2 months ago
Enterprise value to revenue forward of Philogen SpA – MIL:PHIL
Enterprise value to revenue forward of Philogen SpA – MIL:PHIL
TradingView · 3 months ago
Number of shareholders of Philogen SpA – LSX:A2QQB6
Number of shareholders of Philogen SpA – LSX:A2QQB6
TradingView · 4 months ago
Dividend history of Philogen, Dividend date of Philogen, Dividend data of Philogen, Dividend Calendar of Philogen
Dividend history of Philogen, Dividend date of Philogen, Dividend data of Philogen, Dividend Calendar of Philogen
RTTNews · 4 months ago
Philogen ends Q1 with declining NFP; share buyback launched
Philogen ends Q1 with declining NFP; share buyback launched
marketscreener.com · 4 months ago
Philogen Details Voting Rights Structure Ahead of April 29 Shareholders’ Meeting
Philogen Details Voting Rights Structure Ahead of April 29 Shareholders’ Meeting
TipRanks · 5 months ago
Earnings call transcript: Philogen’s H2 2025 highlights strong financials and product innovation
Earnings call transcript: Philogen’s H2 2025 highlights strong financials and product innovation
Investing.com · 6 months ago
Sun Pharma Partner Philogen Reports Mixed Phase II Results, Plans Registrational Studies
Sun Pharma Partner Philogen Reports Mixed Phase II Results, Plans Registrational Studies
scanx.trade · 6 months ago